Leerink Partners Starts Loxo Oncology (LOXO) at Outperform
Tweet
Share
E-mail
Get Alerts LOXO Hot Sheet
Price: $234.80 --0%
Rating Summary:
7 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 13 | New: 19
Rating Summary:
7 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 13 | New: 19
Join SI Premium – FREE
Leerink Partners analyst Andrew Berens initiates coverage on Loxo Oncology (NASDAQ: LOXO) with a Outperform rating and a price target of $205.00.
For an analyst ratings summary and ratings history on Loxo Oncology click here. For more ratings news on Loxo Oncology click here.
Shares of Loxo Oncology closed at $159.27 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Starts Power Grid Corp of India Ltd (PWGR:IN) at Buy
- DZ Bank Starts Enphase Energy (ENPH) at Hold
- Mizuho Starts Regency Centers (REG) at Neutral
Create E-mail Alert Related Categories
New CoverageRelated Entities
Andrew BerensSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
